Alere progresses in Q3, with more to come
This article was originally published in Clinica
Executive Summary
Alere’s third-quarter results came in ahead of analyst expectations, with sales of $753.9m beating predictions of $738.5m. The quarter “showed progress on growth and debt service goals,” with “more progress in store for 2014,” according to Jefferies analyst Raj Denhoy.